Literature DB >> 6787189

Mutagenicity of N-acylglycinohydroxamic acids and related compounds.

K Munakata, H Mochida, S Kondo, Y Suzuki.   

Abstract

The mutagenic activity of twenty-nine new N-acylglycinohydroxamic acids and related compounds was tested on Bacillus subtilis (Rec(+), Rec(-)) and Salmonella typhimurium (TA 98, TA 100). All the N-(substituted-benzoyl)glycinohydroxamic acids, except 3-acetylaminobenzoyl-derivative, were shown to be mutagenic to both test bacteria, whereas most of the N-aliphatic acylglycinohydroxamic acids were found to be non-mutagenic. In the present study, we discussed out observations focussing on the structure-activity correlation between their chemical structures and mutagenic activities.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6787189     DOI: 10.1248/bpb1978.3.557

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  5 in total

1.  Treatment of infected urinary stones in rats by a new hydroxamic acid, "N-(pivaloyl)glycinohydroxamic acid.

Authors:  H Takeuchi; Y Okada; K Kobashi; O Yoshida
Journal:  Urol Res       Date:  1982

2.  Stone formation by Ureaplasma urealyticum in human urine and its prevention by urease inhibitors.

Authors:  S Takebe; A Numata; K Kobashi
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

3.  Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget?

Authors:  Sida Shen; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2015-11-25       Impact factor: 3.466

4.  Assessment of the trifluoromethyl ketone functionality as an alternative zinc-binding group for selective HDAC6 inhibition.

Authors:  Yves Depetter; Silke Geurs; Flore Vanden Bussche; Rob De Vreese; Jorick Franceus; Tom Desmet; Olivier De Wever; Matthias D'hooghe
Journal:  Medchemcomm       Date:  2018-05-18       Impact factor: 3.597

Review 5.  Alternative Therapeutic Options to Antibiotics for the Treatment of Urinary Tract Infections.

Authors:  Paul Loubet; Jérémy Ranfaing; Aurélien Dinh; Catherine Dunyach-Remy; Louis Bernard; Franck Bruyère; Jean-Philippe Lavigne; Albert Sotto
Journal:  Front Microbiol       Date:  2020-07-03       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.